Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 401 entries
View as:

Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00187109 Org: User:
Start: 06/30/00 End: 02/28/07 Due: 02/28/08

Genetic Study of Families With High Frequency of Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02795013 Org: User:
Start: 08/17/16 End: 02/27/18 Due: 02/27/19

Treatment of Burkitt Lymphoma/Leukemia and B Large Cell NHL

Phase: N/A Priority: Normal
NCT ID: NCT00187161 Org: User:
Start: 11/30/94 End: 01/31/07 Due: 01/31/08

A Pediatric Study of a Plerixafor Containing Regimen In Second Allogeneic Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT01068301 Org: User:
Start: 05/31/10 End: 10/31/13 Due: 10/31/14

Methotrexate or Pentostatin for Graft-versus-host Disease Prophylaxis in Risk-adapted Allogeneic Bone Marrow Transplantation for Hematologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01188798 Org: User:
Start: 09/30/10 End: 02/29/12 Due: 02/28/13

State Of The Art Functional Imaging In Sickle Cell Disease

Phase: N/A Priority: Normal
NCT ID: NCT01137721 Org: User:
Start: 09/30/10 End: 06/30/16 Due: 06/30/17

Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06533748 Org: User:
Start: 01/23/25 End: 05/31/34 Due: 05/31/35

Sickle Cell Clinical Research and Intervention Program

Phase: N/A Priority: Normal
NCT ID: NCT02098863 Org: User:
Start: 04/15/14 End: 12/31/44 Due: 12/31/45

Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)

Phase: N/A Priority: Normal
NCT ID: NCT06390319 Org: User:
Start: 12/27/24 End: 12/31/33 Due: 12/31/34

TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT03849651 Org: User:
Start: 01/31/19 End: 08/07/25 Due: 08/07/26

Impact of Resistance Training-Protein Supplementation on Lean Muscle Mass in Childhood Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT02501460 Org: User:
Start: 08/17/15 End: 01/30/18 Due: 01/30/19

Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03194906 Org: User:
Start: 11/07/17 End: 06/28/23 Due: 06/28/24

Remote Exercise Video Adaptations to Maximize Physical Activity in Childhood Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06411704 Org: User:
Start: 06/06/24 End: 06/30/26 Due: 06/30/27

Aerobic and Strengthening Exercise for Acute Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00766311 Org: User:
Start: 01/31/08 End: 12/31/11 Due: 12/31/12

Medical Treatment Decision Making Using Adaptive Conjoint Analysis

Phase: N/A Priority: Normal
NCT ID: NCT02608307 Org: User:
Start: 02/09/16 End: 10/17/19 Due: 10/17/20

Dose-Escalation Study Of A Self Complementary Adeno-Associated Viral Vector For Gene Transfer in Hemophilia B

Phase: N/A Priority: Normal
NCT ID: NCT00979238 Org: User:
Start: 02/22/10 End: 12/31/32 Due: 12/31/33

Long Term Effects of Erythrocyte Lysis

Phase: N/A Priority: Normal
NCT ID: NCT00842621 Org: User:
Start: 03/31/09 End: 06/30/16 Due: 06/30/17

Evaluating Therapeutic Boundaries Among Bedside Nurses At A Pediatric Hematology/Oncology Research Hospital

Phase: N/A Priority: Normal
NCT ID: NCT01355731 Org: User:
Start: 05/31/11 End: 06/30/11 Due: 06/30/12

Therapy for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00137111 Org: User:
Start: 07/08/00 End: 04/30/14 Due: 04/30/15

Constraint-Induced Movement Therapy in a Pediatric Oncology Population

Phase: N/A Priority: Normal
NCT ID: NCT01447810 Org: User:
Start: 10/31/11 End: 12/31/13 Due: 12/31/14

Response to Influenza Vaccination in Pediatric Oncology Patients

Phase: N/A Priority: Normal
NCT ID: NCT05384288 Org: User:
Start: 10/07/22 End: 12/31/27 Due: 12/31/28

Determination of the Sensitivity and Specificity of a Smartphone Application to Detect Retinoblastoma

Phase: N/A Priority: Normal
NCT ID: NCT03016156 Org: User:
Start: 03/15/18 End: 07/30/26 Due: 07/30/27

Light Therapy to Increase Energy in Adolescents and Young Adults Newly Diagnosed With Solid Tumors: A Pilot Study

Phase: N/A Priority: Normal
NCT ID: NCT02429063 Org: User:
Start: 07/17/15 End: 05/03/22 Due: 05/03/23

A Phase II Pediatric Study of a Graft-VS.-Host Disease (GVHD) Prophylaxis Regimen With no Calcineurin Inhibitors After Day +60 Post First Allogeneic Hematopoietic Cell Transplant for Hematological Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT05579769 Org: User:
Start: 03/14/23 End: 05/08/24 Due: 05/08/25

Feasibility of Screening for Early Late Effects of Contemporary Therapy in High-Risk Neuroblastoma Survivors

Phase: N/A Priority: Normal
NCT ID: NCT06480526 Org: User:
Start: 10/21/24 End: 12/31/28 Due: 12/31/29